STAGE III BREAST CANCER AJCC V7

This study is testing whether a newer hormone therapy drug called Z-Endoxifen works better than the standard drug tamoxifen for controlling advanced breast cancer. It involves 81 postmenopausal women whose cancer has spread, is fueled by estrogen, and has stopped responding to in…

This large Phase 3 trial is testing whether adding a year of the immunotherapy drug pembrolizumab after standard chemotherapy and surgery can help prevent cancer from returning in patients with high-risk triple-negative breast cancer. The study enrolled over 1,100 patients whose …

This study is testing whether a comprehensive lifestyle program can improve outcomes for people with stage II or III breast cancer who are undergoing radiation therapy. The program includes dietary coaching, exercise, stress management, and social support. Researchers want to see…

This early-stage trial aims to find safe doses and understand side effects of several drug combinations for patients with advanced cancers that haven't responded to standard treatments. The study involves 155 participants with various advanced or metastatic cancers and some rare …

This study is testing whether taking two oral drugs, cediranib and olaparib, together can help control advanced cancers that have spread or cannot be surgically removed. It is for adults with specific types of advanced lung, breast, or pancreatic cancer who have already tried at …

This study is testing if adding an immunotherapy drug (atezolizumab) to standard chemotherapy before surgery works better for treating early-stage triple-negative breast cancer. It will compare two groups: one gets chemo alone, and the other gets chemo plus the immunotherapy drug…

This study is testing whether a form of acupuncture using mild electrical currents can help reduce long-term pain in women who have been treated for early-stage breast cancer. It will involve 111 women who have had persistent pain for at least 3 months after finishing cancer trea…